Rob Daniels
Director & CEO
Pharmaceutical sciences
Elastagen
Australia
Biography
Rob has successfully guided Elastagen from its early research phases through to the current clinical development of its tropoelastin based treatments for the rapidly growing medical and aesthetic markets. Prior to joining Elastagen Rob had spent the previous ten years working across a broad range of the life science industry including contract research, medical devices and therapeutics. He has been successful in raising capital; managing in- and out- licensing programs; joint venture creation; and, managing product development programs through to the clinic. Robert’s experience includes University spin-outs through to listed companies; and, he has worked in the UK, Australia and Hong Kong.
Research Interest
Pharmaceutical sciences